Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Nov;83(21):8024–8028. doi: 10.1073/pnas.83.21.8024

Characterization of cDNA coding for human factor XIIIa.

U Grundmann, E Amann, G Zettlmeissl, H A Küpper
PMCID: PMC386859  PMID: 2877457

Abstract

A cDNA library prepared from human placenta has been screened for sequences coding for factor XIIIa, the enzymatically active subunit of the factor XIII complex that stabilizes blood clots through crosslinking of fibrin molecules. Two oligonucleotides, based on the amino acid sequences of tryptic peptides of factor XIIIa, were used as hybridization probes. Of 0.36 X 10(6) independent recombinants, 1 clone was identified that hybridized to both probes. The insert of 1704 base pairs coded for the amino-terminal 541 amino acid residues of the mature factor XIIIa molecule. Blot-hybridization analysis using this cDNA as a probe showed that the factor XIIIa mRNA from placenta has a size of approximately 4000 bases. The insert was used to rescreen cDNA libraries and to identify further factor XIIIa-specific sequences. The total length of the isolated factor XIIIa cDNA is 3905 bases, and it codes for a protein of 732 amino acids. In spite of the presence of factor XIII in blood plasma, we could not identify a leader sequence typical for secreted proteins.

Full text

PDF
8024

Images in this article

8026Image
on p.8026
8026Image
on p.8026

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aviv H., Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A. 1972 Jun;69(6):1408–1412. doi: 10.1073/pnas.69.6.1408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baralle F. E., Brownlee G. G. AUG is the only recognisable signal sequence in the 5' non-coding regions of eukaryotic mRNA. Nature. 1978 Jul 6;274(5666):84–87. doi: 10.1038/274084a0. [DOI] [PubMed] [Google Scholar]
  3. Board P. G. Genetic polymorphism of the A subunit of human coagulation factor XIII. Am J Hum Genet. 1979 Mar;31(2):116–124. [PMC free article] [PubMed] [Google Scholar]
  4. Board P. G. Genetic polymorphism of the B subunit of human coagulation factor XIII. Am J Hum Genet. 1980 May;32(3):348–353. [PMC free article] [PubMed] [Google Scholar]
  5. Board P. G., Reid M., Serjeantson S. The gene for coagulation factor XIII a subunit (F13A) is distal to HLA on chromosome 6. Hum Genet. 1984;67(4):406–408. doi: 10.1007/BF00291400. [DOI] [PubMed] [Google Scholar]
  6. Bohn H., Becker W., Trobisch H. Die molekulare Struktur der fibrinstablisierenden Faktoren des Menschen. II. Vergleichennde immunologische Untersuchungen von Faktor-XIII-Mangelplasmen und Normalplasma. Blut. 1973 May;26(5):303–311. doi: 10.1007/BF01638695. [DOI] [PubMed] [Google Scholar]
  7. Bohn H., Schwick H. G. Isolierung und Charakterisierung eines fibrinstabilisierenden Faktors aus menschlichen Plazenten. Arzneimittelforschung. 1971 Oct;21(10):1432–1439. [PubMed] [Google Scholar]
  8. Bohn H. The human fibrin-stabilizing factors. Mol Cell Biochem. 1978 Jun 28;20(2):67–75. doi: 10.1007/BF00241384. [DOI] [PubMed] [Google Scholar]
  9. Boissel J. P., Kasper T. J., Shah S. C., Malone J. I., Bunn H. F. Amino-terminal processing of proteins: hemoglobin South Florida, a variant with retention of initiator methionine and N alpha-acetylation. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8448–8452. doi: 10.1073/pnas.82.24.8448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Castle S. L., Board P. G. Biochemical characterisation of genetically variant and abnormal blood coagulation factor XIII A subunits. Clin Chim Acta. 1983 Sep 30;133(2):141–151. doi: 10.1016/0009-8981(83)90399-6. [DOI] [PubMed] [Google Scholar]
  11. Castle S., Board P. G., Anderson R. A. Genetic heterogeneity of factor XIII deficiency: first description of unstable A subunits. Br J Haematol. 1981 Jun;48(2):337–342. [PubMed] [Google Scholar]
  12. Chan Y. L., Gutell R., Noller H. F., Wool I. G. The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal ribonucleic acid. J Biol Chem. 1984 Jan 10;259(1):224–230. [PubMed] [Google Scholar]
  13. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  14. Curtis C. G., Lorand L. Fibrin-stabilizing factor (factor XIII). Methods Enzymol. 1976;45:177–191. doi: 10.1016/s0076-6879(76)45018-8. [DOI] [PubMed] [Google Scholar]
  15. Folk J. E., Finlayson J. S. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem. 1977;31:1–133. doi: 10.1016/s0065-3233(08)60217-x. [DOI] [PubMed] [Google Scholar]
  16. Gubler U., Hoffman B. J. A simple and very efficient method for generating cDNA libraries. Gene. 1983 Nov;25(2-3):263–269. doi: 10.1016/0378-1119(83)90230-5. [DOI] [PubMed] [Google Scholar]
  17. Holbrook J. J., Cooke R. D., Kingston I. B. The amino acid sequence around the reactive cysteine residue in human plasma Factor XII. Biochem J. 1973 Dec;135(4):901–903. doi: 10.1042/bj1350901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kozak M. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 1984 Jan 25;12(2):857–872. doi: 10.1093/nar/12.2.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 1986 Jan 31;44(2):283–292. doi: 10.1016/0092-8674(86)90762-2. [DOI] [PubMed] [Google Scholar]
  20. Lathe R. Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations. J Mol Biol. 1985 May 5;183(1):1–12. doi: 10.1016/0022-2836(85)90276-1. [DOI] [PubMed] [Google Scholar]
  21. Lorand L., Credo R. B., Janus T. J. Factor XIII (fibrin-stabilizing factor). Methods Enzymol. 1981;80(Pt 100):333–341. doi: 10.1016/s0076-6879(81)80029-8. [DOI] [PubMed] [Google Scholar]
  22. Maxam A. M., Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1977 Feb;74(2):560–564. doi: 10.1073/pnas.74.2.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mosher D. F. Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. J Biol Chem. 1975 Aug 25;250(16):6614–6621. [PubMed] [Google Scholar]
  24. Mosher D. F., Schad P. E. Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. J Clin Invest. 1979 Sep;64(3):781–787. doi: 10.1172/JCI109524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nakamura S., Iwanaga S., Suzuki T., Mikuni Y., Konishi K. Amino acid sequence of the peptide released from bovine factor XIII following activation by thrombin. Biochem Biophys Res Commun. 1974 May 7;58(1):250–256. doi: 10.1016/0006-291x(74)90919-x. [DOI] [PubMed] [Google Scholar]
  26. Palmiter R. D., Gagnon J., Walsh K. A. Ovalbumin: a secreted protein without a transient hydrophobic leader sequence. Proc Natl Acad Sci U S A. 1978 Jan;75(1):94–98. doi: 10.1073/pnas.75.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sakata Y., Aoki N. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest. 1980 Feb;65(2):290–297. doi: 10.1172/JCI109671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sixma J. J., van den Berg A., Schiphorst M., Geuze H. J., McDonagh J. Immunocytochemical localization of albumin and factor XIII in thin cryo sections of human blood platelets. Thromb Haemost. 1984 Jul 29;51(3):388–391. [PubMed] [Google Scholar]
  30. Smith H. O., Birnstiel M. L. A simple method for DNA restriction site mapping. Nucleic Acids Res. 1976 Sep;3(9):2387–2398. doi: 10.1093/nar/3.9.2387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  32. Takagi T., Doolittle R. F. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry. 1974 Feb 12;13(4):750–756. doi: 10.1021/bi00701a018. [DOI] [PubMed] [Google Scholar]
  33. Takahashi N., Takahashi Y., Putnam F. W. Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8019–8023. doi: 10.1073/pnas.83.21.8019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wallner B. P., Mattaliano R. J., Hession C., Cate R. L., Tizard R., Sinclair L. K., Foeller C., Chow E. P., Browing J. L., Ramachandran K. L. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature. 1986 Mar 6;320(6057):77–81. doi: 10.1038/320077a0. [DOI] [PubMed] [Google Scholar]
  35. Woods D. E., Markham A. F., Ricker A. T., Goldberger G., Colten H. R. Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5661–5665. doi: 10.1073/pnas.79.18.5661. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES